UCLA SPOREs in Cancer
![Cancer researcher holding test tube in lab](/sites/default/files/styles/landscape_3x2_016000_640x427_mobile_hero/public/banner-images/dd/female-researcher-holding-test-tube-lab.jpg?h=9fc99804&f=2c34705c&itok=J_URVXV_)
Specialized Programs of Research Excellence
The National Cancer Institutes (NCI) currently funds Specialized Programs of Research Excellence grants, or SPOREs, which are located at select academic centers in across the United States. The brain and prostate cancer programs at the UCLA Jonsson Comprehensive Cancer Center have each been designated a SPORE by the NCI, making them among the select few such programs nationwide to receive this national recognition and substantial research funding.
![Doctor holding a virtual brain scan](/sites/default/files/styles/landscape_16x9_016000_640x360/public/images/ba/male-doctor-holding-virtual-brain-copy.jpg?f=9198e76d&itok=VN6Vy0Na)
SPORE in Brain Cancer
As a designated SPORE site, the UCLA Brain Tumor Program supports research into the prevention, detection and treatment of one of the most lethal and deadly cancers, which often receives far less funding than other types of cancers.
![Prostate cancer cells](/sites/default/files/styles/landscape_16x9_016000_640x360/public/images/ee/prostate-cancer-cells.jpg?h=73cf094d&f=32feb5d3&itok=ChfjbEFh)
SPORE in Prostate Cancer
The UCLA SPORE in Prostate Cancer seeks to contribute significantly to progress in the diagnosis, prevention, and treatment of prostate cancer, which is accomplished through multiple and diverse research projects in basic science and population-based research,
Related News & Discoveries
![Kyung Sung](/sites/default/files/styles/landscape_3x2_016000_640x427/public/images/75/kyung-sung.jpg?f=359b61e8&itok=hpn9AW_T)
![David Nathanson, Benjamin Ellingson and Timothy Cloughesy](/sites/default/files/styles/landscape_3x2_016000_640x427/public/images/ac/2023-08-23-uclah-jccc-cloughesy-ellingson-nathanson-038.jpg?f=591ef579&itok=jwxXVO-0)
![Prostate cancer cell](/sites/default/files/styles/landscape_3x2_016000_640x427/public/images/prostate-cancer-cell_0.jpg?h=9c86ceb9&itok=OeoNiddU)
![Dr. Jeffrey Ardell, director of the UCLA Neurocardiology Research Program of Excellence, has full confidence in the medical team treating him for prostate cancer. That team includes Dr. Matthew Rettig, medical director of the Prostate Cancer Program of the Institute of Urologic Oncology at UCLA. (Photo by Joshua Sudock/UCLA Health)](/sites/default/files/styles/landscape_3x2_016000_640x427/public/images/4c/rettig-ardell.jpg?h=f680b6b0&f=7ec688f9&itok=G6gmDIxM)